Post Hoc Analysis of the Phase II/III APRIL‐SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL

OBJECTIVE: To assess the relationship between treatment response, baseline biomarker levels, and atacicept exposure in patients with systemic lupus erythematosus (SLE) in the phase II/III APRIL‐SLE study. METHODS: We performed a post hoc analysis of patients who received placebo, atacicept 75 mg, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Caroline, Wofsy, David, Wax, Stephen, Li, Yong, Pena Rossi, Claudia, Isenberg, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Systemic Lupus Erythematosus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681010/
https://www.ncbi.nlm.nih.gov/pubmed/27390168
http://dx.doi.org/10.1002/art.39809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681010/
https://www.ncbi.nlm.nih.gov/pubmed/27390168
http://dx.doi.org/10.1002/art.39809

Ejemplares similares